Published in J Exp Med on July 21, 2003
The biology of Hodgkin's lymphoma. Nat Rev Cancer (2008) 3.31
Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J (2006) 1.79
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer (2005) 1.36
Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol (2007) 1.05
Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities. Leukemia (2014) 1.04
Role of Smac/DIABLO in cancer progression. J Exp Clin Cancer Res (2008) 1.00
Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation. EMBO J (2007) 0.96
Essential role of TAK1 in regulating mantle cell lymphoma survival. Blood (2012) 0.95
Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice. J Biol Chem (2012) 0.93
BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella. EMBO J (2014) 0.91
High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer. Radiat Oncol (2015) 0.84
Cytochrome c oxidase deficiency accelerates mitochondrial apoptosis by activating ceramide synthase 6. Cell Death Dis (2015) 0.83
Elevated XIAP expression alone does not confer chemoresistance. Br J Cancer (2010) 0.83
Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication. BMC Cancer (2010) 0.83
Cyclin-dependent kinases regulate apoptosis of intestinal epithelial cells. Apoptosis (2014) 0.80
Novel therapies for Hodgkin Lymphoma. Ther Adv Hematol (2010) 0.75
Key regulators of apoptosis execution as biomarker candidates in melanoma. Mol Cell Oncol (2014) 0.75
The role of apoptosis in the pathology of pancreatic cancer. Cancers (Basel) (2010) 0.75
Minute kinetics of proapoptotic proteins: BAX and Smac/DIABLO in living tumor cells revealed by homeostatic confocal microscopy. Cytotechnology (2004) 0.75
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies. Blood Lymphat Cancer (2017) 0.75
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (1997) 24.57
Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell (2000) 11.90
Two CD95 (APO-1/Fas) signaling pathways. EMBO J (1998) 10.42
IAP family proteins--suppressors of apoptosis. Genes Dev (1999) 9.96
Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A (1998) 6.69
A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature (2001) 6.62
IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J (1998) 5.28
Caspase-9 can be activated without proteolytic processing. J Biol Chem (1999) 3.20
Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell (2002) 3.06
Biochemical characteristics of caspases-3, -6, -7, and -8. J Biol Chem (1997) 3.04
Dimer formation drives the activation of the cell death protease caspase 9. Proc Natl Acad Sci U S A (2001) 3.04
Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med (1998) 2.78
Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J (2001) 2.06
FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J Biol Chem (1997) 2.01
Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in cardiac myocytes. J Mol Cell Cardiol (2001) 1.97
A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J Biol Chem (1997) 1.82
Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood (2001) 1.64
Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem Sci (2002) 1.53
Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Cancer Res (2001) 1.39
Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis. Cell Death Differ (2002) 0.97
Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95. Exp Hematol (2000) 0.90
Clonality and germinal centre B-cell derivation of Hodgkin/Reed-Sternberg cells in Hodgkin's disease. Ann Oncol (1998) 0.86
Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature (2011) 6.31
A unified model for apical caspase activation. Mol Cell (2003) 6.12
Mechanisms of caspase activation. Curr Opin Cell Biol (2003) 5.54
The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J (2004) 4.85
The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol (2007) 4.64
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep (2006) 4.15
Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature (2010) 4.10
Human caspases: activation, specificity, and regulation. J Biol Chem (2009) 3.67
An IAP-IAP complex inhibits apoptosis. J Biol Chem (2004) 2.82
The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem (2005) 2.47
Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients. J Mol Diagn (2003) 2.41
Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem (2003) 2.30
XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J (2005) 2.27
Activity-based probes that target diverse cysteine protease families. Nat Chem Biol (2005) 2.21
The apoptosome activates caspase-9 by dimerization. Mol Cell (2006) 2.20
The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature (2008) 2.11
Activation of caspases-8 and -10 by FLIP(L). Biochem J (2004) 2.11
RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol Cell (2011) 2.06
Emerging principles in protease-based drug discovery. Nat Rev Drug Discov (2010) 2.05
Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. J Biol Chem (2010) 1.99
Caspases: keys in the ignition of cell death. Chem Rev (2002) 1.91
Regulation of the Apaf-1-caspase-9 apoptosome. J Cell Sci (2010) 1.91
Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J Biol Chem (2008) 1.85
Profiling constitutive proteolytic events in vivo. Biochem J (2007) 1.78
Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol (2010) 1.66
Role of proteolysis in caspase-8 activation and stabilization. Biochemistry (2007) 1.64
Caspases: opening the boxes and interpreting the arrows. Cell Death Differ (2002) 1.64
Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs. J Biol Chem (2007) 1.61
Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer (2004) 1.53
Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem Sci (2002) 1.53
Structural and kinetic determinants of protease substrates. Nat Struct Mol Biol (2009) 1.52
Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis. J Biol Chem (2008) 1.49
Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death. Mol Cell (2010) 1.44
Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Mol Cell (2006) 1.43
Human caspase-7 activity and regulation by its N-terminal peptide. J Biol Chem (2003) 1.37
DeSUMOylating enzymes--SENPs. IUBMB Life (2008) 1.37
Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis. Proc Natl Acad Sci U S A (2002) 1.35
A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis. Biochem J (2009) 1.33
Aminopeptidase fingerprints, an integrated approach for identification of good substrates and optimal inhibitors. J Biol Chem (2009) 1.33
Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene (2002) 1.33
Identification of proteolytic cleavage sites by quantitative proteomics. J Proteome Res (2007) 1.32
Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP. Biochem J (2005) 1.31
Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A (2011) 1.30
Sequential autolytic processing activates the zymogen of Arg-gingipain. J Biol Chem (2003) 1.27
Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition. J Biol Chem (2004) 1.27
Apoptotic caspase activation and activity. Methods Mol Biol (2008) 1.26
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol (2013) 1.26
Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr Pharm Des (2002) 1.23
Capnocytophaga canimorsus: a human pathogen feeding at the surface of epithelial cells and phagocytes. PLoS Pathog (2008) 1.22
Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1. Mol Cell (2009) 1.22
Mitochondrial pathway of apoptosis is ancestral in metazoans. Proc Natl Acad Sci U S A (2012) 1.21
Improved diagnosis of mycobacterial infections in formalin-fixed and paraffin-embedded sections with nested polymerase chain reaction. APMIS (2005) 1.21
Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9. Biochem J (2007) 1.20
Activity profiling of human deSUMOylating enzymes (SENPs) with synthetic substrates suggests an unexpected specificity of two newly characterized members of the family. Biochem J (2008) 1.18
Community-acquired pneumonia due to Bordetella holmesii in a patient with frequently relapsing nephrotic syndrome. J Infect (2006) 1.17
Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity. Cancer Res (2012) 1.16
Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. J Biol Chem (2002) 1.15
Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. J Biol Chem (2003) 1.14
Engineered hybrid dimers: tracking the activation pathway of caspase-7. Mol Cell (2006) 1.14
Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. J Neurosci (2011) 1.13
Identification of ubiquitination sites on the X-linked inhibitor of apoptosis protein. Biochem J (2003) 1.12
Mutations in gyrA and parC associated with resistance to fluoroquinolones in epidemiologically defined clinical strains of Acinetobacter baumannii. J Antimicrob Chemother (2003) 1.11
Probing the S1 specificity pocket of the aminopeptidases that generate antigenic peptides. Biochem J (2011) 1.10
Caspase-8 cleaves histone deacetylase 7 and abolishes its transcription repressor function. J Biol Chem (2008) 1.09
Prevalence of Capnocytophaga canimorsus in dogs and occurrence of potential virulence factors. Microbes Infect (2009) 1.08
Positional-scanning fluorigenic substrate libraries reveal unexpected specificity determinants of DUBs (deubiquitinating enzymes). Biochem J (2008) 1.08
Caspase substrates and inhibitors. Cold Spring Harb Perspect Biol (2013) 1.07
Inhibitor specificity of recombinant and endogenous caspase-9. Biochem J (2002) 1.07
The dynamics and mechanism of SUMO chain deconjugation by SUMO-specific proteases. J Biol Chem (2011) 1.06
Proliferative versus apoptotic functions of caspase-8 Hetero or homo: the caspase-8 dimer controls cell fate. Biochim Biophys Acta (2011) 1.04
Capnocytophaga canimorsus resists phagocytosis by macrophages and blocks the ability of macrophages to kill other bacteria. Immunobiology (2008) 1.03
Synthetic substrates for measuring activity of autophagy proteases: autophagins (Atg4). Autophagy (2010) 1.03
Caspase activation. Biochem Soc Symp (2003) 1.02
Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models. Chem Biol (2010) 1.02
Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum. PLoS One (2012) 1.00
Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases. J Med Chem (2004) 0.99
Functional characterization of a SUMO deconjugating protease of Plasmodium falciparum using newly identified small molecule inhibitors. Chem Biol (2011) 0.99
Early processing of Bid and caspase-6, -8, -10, -14 in the canine brain during cardiac arrest and resuscitation. Exp Neurol (2004) 0.98
Activation and specificity of human caspase-10. Biochemistry (2010) 0.98
Characteristics of the caspase-like catalytic domain of human paracaspase. Biol Chem (2004) 0.98
Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10. J Med Chem (2006) 0.97
Activation and substrate specificity of caspase-14. Biochemistry (2004) 0.97
An optimized activity-based probe for the study of caspase-6 activation. Chem Biol (2012) 0.97
The BIR domain of IAP-like protein 2 is conformationally unstable: implications for caspase inhibition. Biochem J (2005) 0.97
Caspases on the brain. J Neurosci Res (2002) 0.96
Mechanism and specificity of the human paracaspase MALT1. Biochem J (2012) 0.96
Carboxyl-terminal proteolytic processing of CUX1 by a caspase enables transcriptional activation in proliferating cells. J Biol Chem (2007) 0.95
Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death. Neuromolecular Med (2002) 0.95
Design of ultrasensitive probes for human neutrophil elastase through hybrid combinatorial substrate library profiling. Proc Natl Acad Sci U S A (2014) 0.93
Expression, purification, and characterization of caspases. Curr Protoc Protein Sci (2003) 0.92
Small molecules not direct activators of caspases. Nat Chem Biol (2007) 0.92
The influence of immunohistochemistry on mRNA recovery from microdissected frozen and formalin-fixed, paraffin-embedded sections. Diagn Mol Pathol (2004) 0.92
Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases. J Med Chem (2002) 0.92
Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAP. ACS Chem Biol (2013) 0.89
Cytokine response modifier a inhibition of initiator caspases results in covalent complex formation and dissociation of the caspase tetramer. J Biol Chem (2006) 0.88
Vaccinia virus protein F1L is a caspase-9 inhibitor. J Biol Chem (2009) 0.87